Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

(03) 9028 2888

clients@freshequities.com

AdAlta Limited

INVESTOR PRESENTATION - AdAlta Limited

ASX:1AD

AdAlta Limited

Health

AdAlta is an innovative biotech company developing a unique range of new drug treatments. AdAlta has pioneered a technology that mimics the shape and stability of a crucial antigen-binding domain, discovered initially in sharks and then developed as a human protein. The result is a range of unique compounds, now known as i-bodies, for use in treating serious diseases. AdAlta is utilising the power of the i-body technology to create a pipeline of new drugs, with an initial focus on treating fibrotic diseases.

Read more

Market Cap

$35.55m

Price at Close

$0.145

4w avg. Volume

441.17k

4w avg. Turnover

$60.73k

Announcements
announcementt+2 movementdate
  • Phase I HV extension to explore encouraging results

    Progress Report · Market sensitive

  • -7.69%

    13 Dec 2020

-7.69%

13 Dec 2020
  • Change of Director's Interest Notice

    Shareholder Details

  • 0.00%

    29 Nov 2020

0.00%

29 Nov 2020
  • Constitution

    Company Administration

  • 0.00%

    26 Nov 2020

0.00%

26 Nov 2020
  • Results of Meeting

    Notice Of Meeting

  • 0.00%

    25 Nov 2020

0.00%

25 Nov 2020
  • AGM Presentation

    Periodic Reports · Market sensitive

  • 0.00%

    24 Nov 2020

0.00%

24 Nov 2020
  • AGM joining and voting instructions

    Notice Of Meeting

  • 0.00%

    23 Nov 2020

0.00%

23 Nov 2020
  • Notification of Expired Options

    Issued Capital

  • -4.35%

    08 Nov 2020

-4.35%

08 Nov 2020
  • AusBiotech presentation including Phase I status update

    Periodic Reports · Market sensitive

  • -8.00%

    26 Oct 2020

-8.00%

26 Oct 2020
  • Notice of Annual General Meeting/Proxy Form

    Notice Of Meeting

  • +3.70%

    21 Oct 2020

+3.70%

21 Oct 2020
  • Annual General Meeting - Letter to Shareholders

    Notice Of Meeting

  • +3.70%

    21 Oct 2020

+3.70%

21 Oct 2020
Market Data

Current Price

$0.145

52WK HIGH

$0.185

52WK LOW

$0.04

1YR RETURN

+31.82%

1YR RETURN VS. SECTOR

-5.70%

90 DAY RETURN

+11.54%

ASX RANK

1,299

/2,047

SECTOR RANK

123

/168

SHARES OUTSTANDING

245.18m
ASX:1AD

AdAlta Limited

Health

AdAlta is an innovative biotech company developing a unique range of new drug treatments. AdAlta has pioneered a technology that mimics the shape and stability of a crucial antigen-binding domain, discovered initially in sharks and then developed as a human protein. The result is a range of unique compounds, now known as i-bodies, for use in treating serious diseases. AdAlta is utilising the power of the i-body technology to create a pipeline of new drugs, with an initial focus on treating fibrotic diseases.

Read more

Market Cap

$35.55m

Price at Close

$0.145

4w avg. Volume

441.17k

4w avg. Turnover

$60.73k

ASX:1AD is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.